Bio-Techne prepares to report quarterly earnings against a backdrop of declining revenue projections and mixed performances from life sciences peers.
While EcoFirst Consolidated Bhd (KLSE:ECOFIRS) reported statutory profits, a deeper dive into its cash flow and earnings composition reveals underlying concerns that may have been overlooked by the market's muted reaction.
Food distribution leader Performance Food Group (NYSE: PFGC) is scheduled to release its quarterly earnings before markets open on Wednesday, with analysts projecting moderated revenue growth and continued pressure on profitability.
Healthcare distribution giant Cencora (COR) is set to report quarterly earnings before Wednesday's market open. Analysts project steady revenue growth, but investor focus will be on guidance amid mixed performances from sector peers.
All eyes are on Flex (NASDAQ: FLEX) as it prepares to release its fourth-quarter earnings before the market opens on Wednesday. The contract manufacturing leader has consistently outperformed Wall Street's revenue expectations, but can it do so again in a challenging macro environment?
Despite a challenging macroeconomic backdrop, Etsy, Inc. (ETSY) is entering the critical holiday quarter with a bullish setup, driven by surging mobile engagement, effective monetization, and the powerful resurgence of its Depop platform.
Beyond the headlines of cash burn and production woes, Rivian Automotive is executing a strategic pivot. With falling costs, the imminent launch of its mass-market R2, and a growing software revenue stream, the company is laying the groundwork to transform from a pure EV manufacturer into a vertically integrated autonomy platform.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
Global equities and commodities staged a broad recovery on Tuesday, shaking off a pan-Asian rout triggered by a hawkish Fed nominee and geopolitical jitters. The rebound was anchored by surprisingly strong US manufacturing figures, offering a respite to bruised investors.
Lawmakers in the Philippines are deliberating whether to advance impeachment complaints against President Ferdinand Marcos Jr., setting the stage for a political showdown that could test the stability of his administration.
Homeland Security Secretary Kristi Noem will testify before House and Senate committees in March, as lawmakers probe the administration's immigration enforcement tactics following the fatal shootings of two U.S. citizens in Minnesota.
Amid a competitive waste management sector, Waste Connections (WCN) is drawing investor attention for its focus on underserved rural markets and a vast network of landfills that create high barriers to entry. With a recent analysis pointing to significant upside potential, we examine the company's operational leverage, revenue diversification, and the financial metrics underpinning the bullish thesis.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
Amid a challenging home furnishings market, luxury retailer RH is posting resilient results and gaining ground on competitors. A closer look reveals a strategy pivoting on international expansion, high-margin experiential offerings, and disciplined inventory management, setting the stage for ambitious long-term growth.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
Specialist asset manager Cohen & Steers (NYSE: CNS) is attracting bullish attention as its focus on real assets aligns with a shifting monetary policy landscape. After a prolonged period of outflows, the firm is seeing renewed investor interest.
Despite a recent pullback in its share price, e.l.f. Beauty (NYSE: ELF) continues to capture market share and investor attention with its potent mix of viral marketing, retail expansion, and improving profitability. We examine the bull case for the value-centric beauty disruptor.
Amid market volatility, a detailed analysis circulating among value investors makes a case for Kimberly-Clark Corporation. The thesis highlights the household products maker's resilient business model, technical support levels, and a valuation disconnect that could signal a compelling entry point for long-term portfolios.
Amid a volatile tech landscape, Opera Limited (OPRA) presents a compelling, if risky, value proposition. With a profitable core business, a clean balance sheet, and a potentially undervalued stake in African fintech giant Opay, some investors see significant upside despite concerns over revenue concentration and market disruption.
